Nocturia May Be Reduced by Cutting Daily Intake of Salt

Share this content:
Nocturia May Be Reduced by Cutting Daily Intake of Salt
Nocturia May Be Reduced by Cutting Daily Intake of Salt

MONDAY, March 27, 2017 (HealthDay News) -- Lowering salt intake could lead to fewer episodes of nocturia, according to a study presented at the annual meeting of the European Association of Urology, held from March 24 to 28 in London.

Matsuo Tomohiro, M.D., of Nagasaki University in Japan, and colleagues collected data on 321 Japanese adults. All of the participants had high salt intake and sleeping problems. They were given instructions and help to reduce their salt intake and followed for 12 weeks. The American Heart Association recommends that people consume no more than 2,300 milligrams of sodium daily.

The researchers found that 233 individuals in the study reduced their salt intake. They went from an average of 11 g to 8 g per day. With that reduction in salt, the average frequency of nighttime urination fell from 2.3 to 1.4 times per night. The number of times people needed to urinate during the day also decreased. In comparison, the 98 participants whose average salt intake rose -- from 9.6 g to 11 g -- had an increase in frequency of nighttime urination, from 2.3 to 2.7 times a night.

"This is an important aspect of how patients potentially can help themselves to reduce the impact of frequent urination. Research generally focuses on reducing the amount of water a patient drinks, and the salt intake is generally not considered," Marcus Drake, B.M., B.Ch., a professor at the University of Bristol in the United Kingdom, and leader of the working group for the ESU Guidelines Office Initiative on Nocturia, said in a news release from the European Association of Urology. "Here we have a useful study showing how we need to consider all influences to get the best chance of improving the symptom."

Press Release
More Information

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »